Source: Eur Respir J, 54 (5) 1901894; 10.1183/13993003.01894-2019
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Miriam Barrecheguren, Marc Miravitlles. Treatment with inhaled a1-antitrypsin: a square peg in a round hole?. Eur Respir J, 54 (5) 1901894; 10.1183/13993003.01894-2019

Member's Comments

No comment yet.

Related content which might interest you: Inhaled corticosteroid fine particle dose from valved holding chambers Source: Annual Congress 2010 - Drug delivery and pharmacokinetics I Year: 2010 Treating the nose for controlling the lung: a vanishing story? Source: Eur Respir Monogr 2017; 76: 177-192 Year: 2017 Infection: ground glass and airspace opacities Source: ERS Course 2015 Year: 2015 Treatment of COPD and the TOnado trial: a tempest in a teapot? Source: Eur Respir J 2015; 45: 869-871 Year: 2015 Corticosteroid tapering with benralizumab treatment for eosinophilic asthma: PONENTE Trial Source: ERJ Open Res, 5 (3) 00009-2019; 10.1183/23120541.00009-2019 Year: 2019 Corticosteroid and long acting beta agonist combination inhalers in COPD: the right device for the right patient? Source: Eur Respir J 2005; 26: Suppl. 49, 293s Year: 2005 Modulator treatment for people with cystic fibrosis: moving in the right direction Source: Eur Respir Rev, 29 (155) 200051; 10.1183/16000617.0051-2020 Year: 2020 Median mass aerodynamic diameter (MMAD) and fine particle fraction (FPF): Influence on lung deposition? Source: International Congress 2014 – Asthma and COPD devices and treatments Year: 2014 Inhaled medication: which device for which patient? Source: Eur Respir Monogr 2015; 69: 213-223 Year: 2015 Infection: Ground glass and airspace opacities Source: School Course 2013 - Thoracic Imaging Year: 2013 Infection: Ground glass and airspace opacities Source: School Course 2012 - Thoracic Imaging Year: 2012 Infection: Ground glass and airspace opacities Source: ERS Course 2018 - Thoracic imaging Year: 2018 Late Breaking Abstract - Do inhaled carbonaceous particles translocate from the lung to the placenta? Source: International Congress 2018 – Occupational and environmental lung diseases: asthma and the airways Year: 2018 The light at the end of the tunnel: is COPD prevalence changing? Source: Eur Respir J 2010; 36: 718-719 Year: 2010 Inhaled antibiotics: dry or wet? Source: Eur Respir J 2014; 44: 1308-1318 Year: 2014 Alternating inhaled antibiotic therapy in CF: A single center analysis Source: International Congress 2015 – Cystic fibrosis: microbiology, immunology and assessment Year: 2015 Late Breaking Abstract - Exhaled air dispersion during application of CPAP via nasal pillows and oronasal mask versus high flow nasal cannula therapy Source: International Congress 2018 – Hot topics in non-invasive ventilation Year: 2018 Respiratory syncytial virus therapy and prophylaxis: have we finally turned the corner? Source: Eur Respir J 2011; 38: 246-247 Year: 2011 Effects of extra fine formoterol or coarse particle salmeterol on impulse oscillometry (IOS) in corticosteroid treated persistent asthmatics Source: International Congress 2015 – Safety of and interactions between current treatments for asthma and COPD Year: 2015 Late Breaking Abstract - Spatial response to small and large particle bronchodilator in subjects with asthma Source: Virtual Congress 2021 – Hypoxia, exercise and respiratory function in pathophysiological conditions Year: 2021